Safety and efficacy of transoral incisionless fundoplication (TIF2.0) for the treatment of gastroesophageal reflux disease: first results from the European TIF registry (EURO-TIF)
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S128
DOI: 10.1055/s-0046-1820850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von B Norton und 19 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Transoral Incisionless Fundoplication (TIF2.0) is an endoscopic procedure for gastroesophageal reflux disease (GERD), which aims to recreate the oesophageal flap valve using the EsophyX device. TIF2.0 is currently endorsed by the American Society of Gastrointestinal Endoscopy as a mechanical option for patients with proven GERD. We report on the largest dataset outside North America on the safety and efficacy of TIF2.0 conducted within the European TIF registry (EURO-TIF).
Methods
A prospective, multi-centre registry conducted across seven European centres and registered at Cleveland Clinic London (CCL-2021-TIF). All prospectively collected data among patients undergoing TIF2.0 for GERD since 2021 were eligible for inclusion. The primary outcomes were change in reflux-specific quality of life questionnaire (GERD-HRQL) and acid suppression use from baseline to 24-months follow-up. Secondary outcomes included procedural outcomes, changes in oesophageal physiological parameters, and adverse events (AGREE classification). Within-patient changes were analysed using paired t-tests and a linear mixed-effects model. Univariable logistic regression explored predictors of anti-acid discontinuation and AET normalisation.
Results
In total, 261 patients have undergone TIF2.0 with data available on 192. The average age was 47 years (IQR 36-56), 38.5% were female (n=74), and the median Charleson Co-morbidity Index was 0 (IQR 0-1). Most were treatment naïve (97.4%, n=187) and 91.1% (n=175) were on regular anti-acid therapy. A hiatus hernia (HH) was observed in 51.9% (n=97) with an average size of 1 cm (IQR 1-2). Baseline physiological testing was conducted in 161 patients (wireless capsule in 52.5% [n=85]), which showed an average acid exposure time (AET) of 10.1% (IQR 6.8-15.3), total reflux episodes of 86.3 (SD 52.8; catheter-based), and average daily reflux episodes of 58.2 (SD 21.7; wireless). The average GERD-HRQL score at baseline was 19.2 (SD 11.7; n=171) with a dissatisfaction score in 81.4% (n=140). Technical success was 99.5% (n=191), the average procedure time was 39.0 minutes (SD 11.5), an average 14 pairs of plications were used (IQR 10-14), and median inpatient stay was 1 day (IQR 1). Over 30-days, there were 18 adverse events including 12 AGREE grade I, 3 AGREE grade II, and 3 AGREE grade IIIa (bleeding at the fundoplication). At 6-, 12-, and 24-months post-procedure, 78.6% (n=151), 53.6% (n=103), and 18.2% (n=35) were available for follow-up. The average GERD-HRQL was 3.9 (95% CI; 2.7-5.1; p
Zitieren
APA
Norton, B., Telese, A., Stevens, A., Hasan, S., Jasawant, A. S., Weber, H., Bulajic, M., Prampero, S. F. V. D., López-Jurado, R. T., Turro, R., Schoppmann, S., Boğa, S., Skrobic, O. M., Monk, D., Kumar, S., Mohammadi, B., Mughal, M., Simic, A., Staudenmann, D., & Haidry, R. (2026). Safety and efficacy of transoral incisionless fundoplication (TIF2.0) for the treatment of gastroesophageal reflux disease: first results from the European TIF registry (EURO-TIF). Endoscopy, 58(S 03 S 03), S128. https://doi.org/10.1055/s-0046-1820850
Vancouver
Norton B, Telese A, Stevens A, Hasan S, Jasawant AS, Weber H, et al. Safety and efficacy of transoral incisionless fundoplication (TIF2.0) for the treatment of gastroesophageal reflux disease: first results from the European TIF registry (EURO-TIF). Endoscopy. 2026;58(S 03 S 03):S128. doi:10.1055/s-0046-1820850
BibTeX
@article{Norton2026,
author = {Norton, B and Telese, A and Stevens, A and Hasan, S and Jasawant, A S and Weber, H and Bulajic, M and Prampero, S F Vadalà Di and López-Jurado, R Temiño and Turro, R and Schoppmann, S and Boğa, S and Skrobic, O M and Monk, D and Kumar, S and Mohammadi, B and Mughal, M and Simic, A and Staudenmann, D and Haidry, R},
title = {Safety and efficacy of transoral incisionless fundoplication (TIF2.0) for the treatment of gastroesophageal reflux disease: first results from the European TIF registry (EURO-TIF)},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S128},
doi = {10.1055/s-0046-1820850}
}
EUVIMED